Reference
Matsubara Y, et al. Neuroendocrine carcinoma of the stomach: A response to combination chemotherapy consisting of ramucirumab plus paclitaxel. Internal Medicine 57: 671-675, No. 5, 2018. Available from: URL: http://doi.org/10.2169/internalmedicine.9369-17 - Japan
Rights and permissions
About this article
Cite this article
Paclitaxel/ramucirumab. Reactions Weekly 1697, 309 (2018). https://doi.org/10.1007/s40278-018-44865-8
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-018-44865-8